>
Switch to:

Research Frontiers EBIT

: $-1.86 Mil (TTM As of Mar. 2022)
View and export this data going back to 1986. Start your Free Trial

Research Frontiers's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2022 was $-0.58 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2022 was $-1.86 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Research Frontiers's annualized ROC % for the quarter that ended in Mar. 2022 was -170.10%. Research Frontiers's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2022 was -175.21%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Research Frontiers's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2022 was -3.55%.


Research Frontiers EBIT Historical Data

The historical data trend for Research Frontiers's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Research Frontiers Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EBIT
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.42 -2.42 -3.15 -2.58 -1.84

Research Frontiers Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.56 -0.53 0.02 -0.77 -0.58

Research Frontiers EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Research Frontiers  (NAS:REFR) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Research Frontiers's annualized ROC % for the quarter that ended in Mar. 2022 is calculated as:

ROC % (Q: Mar. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2021 ) + Invested Capital (Q: Mar. 2022 ))/ count )
=-2.304 * ( 1 - 0% )/( (1.406 + 1.303)/ 2 )
=-2.304/1.3545
=-170.10 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2022) data.

2. Joel Greenblatt's definition of Return on Capital:

Research Frontiers's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2022 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2022 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2021  Q: Mar. 2022
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-2.304/( ( (0.563 + max(0.809, 0)) + (0.52 + max(0.738, 0)) )/ 2 )
=-2.304/( ( 1.372 + 1.258 )/ 2 )
=-2.304/1.315
=-175.21 %

where Working Capital is:

Working Capital(Q: Dec. 2021 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.832 + 0 + 0.093) - (0.115 + 0 + 0.001)
=0.809

Working Capital(Q: Mar. 2022 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.754 + 0 + 0.086) - (0.091 + 0.011 + -5.5511151231258E-17)
=0.738

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2022) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Research Frontiers's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2022 )
=-1.857/52.259
=-3.55 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Research Frontiers EBIT Related Terms

Thank you for viewing the detailed overview of Research Frontiers's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Research Frontiers Business Description

Research Frontiers logo
Industry
Technology » Hardware NAICS : 334419 SIC : 3679
Traded in Other Exchanges
N/A
Address
240 Crossways Park Drive, Woodbury, NY, USA, 11797-2033
Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. Its revenue source comes from the licensing of technology.
Executives
Douglas Family Trust 10 percent owner, other: 13(d)(3) group 125 E. SIR FRANCIS DRAKE BLVD. SUITE 400 LARKSPUR CA 94939
James & Jean Douglas Irrevocable Descendants Trust 10 percent owner, other: 13(d)(3) group 125 E. SIR FRANCIS DRAKE BLVD. SUITE 400 LARKSPUR CA 94939
Douglas Kevin 10 percent owner, other: 13(d)(3) group 125 E. SIR FRANCIS DRAKE BLVD. SUITE 400 LARKSPUR CA 94939
Settle William Graham director 6003 COBRIDGE SQUARE RALEIGH NC 27609
Lapointe Michael R officer: VP-Marketing PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: LAPOINTE MICHAEL R a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Harary Joseph M director, officer: President and CEO PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: HARARY JOSEPH M a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Van Voorhees Seth officer: CFO & VP-Business Development 12 HARVEY DRIVE SHORT HILLS NJ 07078
Daigle Darryl director 3213 WYTCHWOOD DRIVE MORGAN CITY LA 70380
Kaganowicz Alexander director 1217 CARLLS STRAIGHT PATH DIX HILLS NY 11746
Grimes Gregory George director 24 FIFTH AVENUE APT. 1530 NEW YORK NY 10011
Slovak Steven Michael officer: Vice President-Technology 240 CROSSWAYS PARK DRIVE WOODBURY NY 11797
Saxe Robert L director, officer: Chairman of the Board PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: SAXE ROBERT L a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Keen Victor F director C/O RESEARCH FRONTIERS INC. 240 CROSSWAYS PARK DRIVE WOODBURY NY 11797
Guthrie Marion Philip director THREE LINCOLN CENTRE 5430 LBJ FWY., SUITE 1480 DALLAS TX 75240
Derby Jack director 399 BOYLSTON STREET BOSTON MA 02117

Research Frontiers Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)